FONAR Corporation is engaged in the research, development, production, and marketing of Magnetic Resonance Imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company is headquartered in Melville, New York.
| Revenue (TTM) | $105.34M |
| Gross Profit (TTM) | $42.41M |
| EBITDA | $13.76M |
| Operating Margin | 9.23% |
| Return on Equity | 5.47% |
| Return on Assets | 2.74% |
| Revenue/Share (TTM) | $16.08 |
| Book Value | $27.01 |
| Price-to-Book | 0.67 |
| Price-to-Sales (TTM) | 1.14 |
| EV/Revenue | 0.999 |
| EV/EBITDA | 6.58 |
| Quarterly Earnings Growth (YoY) | -37.10% |
| Quarterly Revenue Growth (YoY) | -2.60% |
| Shares Outstanding | $6.17M |
| Float | $5.48M |
| % Insiders | 16.33% |
| % Institutions | 40.34% |
Volatility is currently expanding
Net Income decreased 25% to $2.3 million for the quarter ended March 31, 2026 as compared to the quarter ended March 31, 2025. Income from Operations for the quarter ended March 31, 2026 decreased 33% to $2.4 million as compared to the quarter ended March 31, 2025.
